glp-1 and gip hormones receptor assay: drug discovery in the metabolic field GLP-1 and GIP in Type

Eknoyan G

Glumasetide Testslycskkents / tvgykontroll

Nunn E, Jaiswal N, Gavin M, et al

Overall, the combined metabolic, neurochemical, and immunomodulatory effects of GLP-1 RAs suggest they could offer therapeutic benefits in mood disorders, especially for patients with coexisting metabolic dysfunction or resistance to standard treatments [15,19,20]

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF

In addition, we discuss the increase in the endogenous secretion of this hormone through various stimuli (e.g., carbohydrates, proteins, gut microbiota, bacteria-derived molecules, bile acids, lipids, fatty acids, polyphenols, etc.) or by the increase of GLP-1-producing cells, i.e., L-cells, which can be an appropriate approach for the management of diabetes